
Sign up to save your podcasts
Or


This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics:
Challenges in achieving treatment targets in AD
Therapeutic inertia and clinical implications of inadequate response
Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies
By LivDerm5
66 ratings
This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?", featuring Beth Sweney, PA-C discusses the following topics:
Challenges in achieving treatment targets in AD
Therapeutic inertia and clinical implications of inadequate response
Comparative clinical data evaluating upadacitinib and dupilumab for treatment of AD
Transitioning to systemic therapies from topical agents, immunosuppressives, and biologic therapies

136 Listeners

25,877 Listeners

112,277 Listeners

1,133 Listeners

16 Listeners

8,529 Listeners

193 Listeners

36 Listeners

143 Listeners

29,186 Listeners

52 Listeners

85 Listeners

6 Listeners

6 Listeners

32 Listeners